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Functional brain networks in the schizophrenia spectrum and
bipolar disorder with psychosis
Edwin van Dellen1,2,7✉, Corinna Börner1,7, Maya Schutte3, Simone van Montfort2, Lucija Abramovic1, Marco P. Boks 1,
Wiepke Cahn 1, Neeltje van Haren1,4, René Mandl1, Cornelis J. Stam5 and Iris Sommer3,6
Psychotic experiences have been proposed to lie on a spectrum, ranging from subclinical experiences to treatment-resistant
schizophrenia. We aimed to characterize functional connectivity and brain network characteristics in relation to the schizophrenia
spectrum and bipolar disorder with psychosis to disentangle neural correlates to psychosis. Additionally, we studied antipsychotic
medication and lithium effects on network characteristics. We analyzed functional connectivity strength and network topology in
487 resting-state functional MRI scans of individuals with schizophrenia spectrum disorder (SCZ), bipolar disorder with a history of
psychotic experiences (BD), treatment-naïve subclinical psychosis (SCP), and healthy controls (HC). Since differences in connectivity
strength may confound group comparisons of brain network topology, we analyzed characteristics of the minimum spanning tree
(MST), a relatively unbiased backbone of the network. SCZ and SCP subjects had a lower connectivity strength than BD and HC
individuals but showed no differences in network topology. In contrast, BD patients showed a less integrated network topology but
no disturbances in connectivity strength. No differences in outcome measures were found between SCP and SCZ, or between BD
patients that used antipsychotic medication or lithium and those that did not. We conclude that functional networks in patients
prone to psychosis have different signatures for chronic SCZ patients and SCP compared to euthymic BD patients, with a limited
role for medication. Connectivity strength effects may have confounded previous studies, as no functional network alterations were
found in SCZ after strict correction for connectivity strength.
npj Schizophrenia            (2020) 6:22 ; https://doi.org/10.1038/s41537-020-00111-6
INTRODUCTION
Psychosis is defined by the experience of hallucinations, delusions,
and the disorganization of thought and speech1. Psychotic
experiences are a core feature of schizophrenia spectrum
disorders (SCZ) but are also highly prevalent in bipolar disorder
(BD)2–4, and in attenuated form in the healthy population
(subclinical psychosis, SCP). As such, psychosis has been proposed
to lie on a spectrum, which ranks these experiences regarding
their severity in clinical and subclinical populations5. Even though
psychotic experiences in SCZ and BD share phenomenological
features4,6,7, it remains unclear to what extent psychosis in BD
shares a common pathophysiology with SCP and SCZ. Disentan-
gling the pathophysiology underlying psychosis in SCP, SCZ, and
BD may help to tailor psychosis treatment based on biological
features.
Neuroimaging studies have provided evidence for the dis-
connection hypothesis in SCZ stating that psychosis in SCZ can be
understood from aberrant anatomical connections and functional
interactions in the brain8,9. Network theory provides a framework
to study structural or functional connections between brain areas
on a systems level, where network nodes represent brain regions
and edges reflect axonal (as measured with diffusion tensor
imaging) or functional connections between nodes10. Several
characteristics have been defined to quantitatively describe the
organization of networks, including the strength or number of
connections that are present (i.e., connectivity strength), the
number of steps it takes to travel across the network (i.e., path
length, a measure of efficiency), and the presence of highly
connected, central hub regions; the so-called rich club11.
In structural brain networks of clinical and subclinical subjects
with psychosis, connectivity strength is generally decreased as
compared to controls12–16. Analysis of network topology char-
acteristics such as efficiency, however, has shown mixed or even
contradicting results15,17–19. In functional networks of subjects
with psychosis, both increases and decreases of connectivity
strength have been reported, as well as mixed results on network
characteristics12,14,20,21. Similarly, studies in BD have not yet led to
consensus on connectivity alterations related to the disorder22–26.
Clinical explanations for the variability of findings in brain network
studies may include differences in studied populations, disease
stages, and medication effects. However, increasing evidence
shows that methodological choices during the imaging data
analysis, ranging from data acquisition to the definition of network
characteristics, may have considerable impact on group
comparisons21,27.
We studied fMRI connectivity and network topology in a large
sample of individuals with SCZ, SCP, BD, and healthy controls (HC),
using strict correction for confounders in network analysis, and
exploring possible effects of antipsychotic medication. We
analyzed resting-state fMRI scans and applied the minimum
spanning tree (MST) analysis to study functional network
topology. The MST is a backbone of the network that is relatively
insensitive to differences in connectivity strength, which often
confound group comparisons of brain network topology, while
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MST characteristics can be interpreted along the lines of
conventional network characteristics27–29 (Fig. 1; Table 1). We
analyzed whether connectivity strength differences can be
disentangled from network topology differences in fMRI func-
tional networks of individuals with a history of psychotic
experiences. In particular, we compared SCP, SCZ, BD with a
history of psychotic episodes, and HC. To investigate possible
medication effects on functional connectivity and network
topology we compared (1) medication-naïve SCP individuals and
SCZ patients (mostly) using antipsychotic medication, and (2) BD
patients that used antipsychotics and those that did not.
RESULTS
Subject characteristics
Subject characteristics are summarized in Table 2. Groups
significantly differed on age (F(3, 483)= 24.02, p < 0.001), sex
(X²(3)= 20.09, p < 0.001), and education (F(3, 483)= 9.74, p <
0.001; see Supplementary Materials: Subject Characteristics).
Motion parameters also differed between the groups (F(3, 486)=
21.586, p < 0.001) with SCZ (M= 0.10, SD= 0.039) and BD patients
(M= 0.10, SD= 0.032) showing more movement during scanning
than SCP individuals (M= 0.08, SD= 0.029) and HC
(M= 0.08, SD= 0.026). However, this was of little influence on
connectivity measures after strict motion correction (see Supple-
mentary Fig. 1).
Group comparisons
Results are summarized in Table 3 (see Supplementary materials:
section matrix visualizations and group comparisons and Supple-
mentary Table 5 for post-hoc test results). SCZ and SCP subjects
had lower connectivity strength than HC and BD individuals (F(3,
480)= 5.62, p= 0.001, ƞ2= 0.034). No differences in global MST
network topology were found between SCZ, SCP, and HC. Mean
connectivity strength in BD patients did not significantly differ
from HC. However, BD patients showed significantly lower kappa
(less diversity in node degree; F(3, 480)= 4.09, p= 0.007, ƞ2=
0.025) and leaf fraction scores (decreased network integration or
efficiency; F(3, 480)= 3.49, p= 0.016, ƞ2= 0.021) than HC and SCP
individuals. We found a nonsignificant trend for a lower kappa
(p= 0.058) and leaf fraction (p= 0.092) in BD compared to SCZ.
Sex had a significant effect as covariate on connectivity strength
Fig. 1 MST visualizations. a–c Brain regions and their connections are visualized as nodes (circles) and edges (lines). Red nodes are leaf nodes
with only one connection. a Path-like MST with a diameter of twelve edges. b Intermediate between a path-like and a star-like MST with a
diameter of six edges. The green node has a higher degree (five connecting edges) than the red leaf nodes. c Star-like MST: The green node is
a node with high betweenness centrality: When connecting any two nodes in the network you have to pass the green node. Kappa, a measure
that characterizes the degree distribution, is highest for a, intermediate for b, and lowest for c.
Table 1. Explanations of minimum spanning tree measures (Stam et al.27; Tewarie et al.29).
MST Measures Definition Interpretation
Connectivity strength
(mean edge)
Mean of edge weights in MST network Connectivity strength
Overlap Fraction of edges that two MSTs have in common Overlap ranges from 0 (no overlapping edges) to 1 (exact match
of MSTs)
Diameter Longest distance between two most remote
nodes (expressed in number of edges)
Indication of network efficiency. A low diameter means that
information is efficiently processed between remote brain regions.
Degree divergence/
Kappa
Measure of the broadness of the degree
distribution
Measure of degree diversity across nodes and importance of hubs. A
high kappa indicates a broader degree distribution and thereby more
hubs are expected. Kappa is related to resilience against attacks.
Leaf fraction Fraction of leaf nodes (nodes with only one
connection) in the MST
Measure of network centrality, integration, and efficiency. A high leaf
fraction means that the network is largely dependent on
central nodes.
Degree Number of edges connected to a given node Measure of regional importance. Nodes with a high degree may be
hub nodes and are more important in the network.
Betweenness centrality
of node X
Fraction of shortest paths between any two nodes
y and z that are passing through x but not
including x
Measure of network centrality (how central a node’s role is in the
overall network communication). When connecting any two nodes in
the network how likely is it to pass node X? Betweenness centrality
ranges from 0 (leaf node) to 1 (central node in a star-like network).
E. van Dellen et al.
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(F(1, 480)= 5.850, p= 0.016, ƞ2= 0.012), with higher connectivity
strength in males. Age had a significant effect as covariate on
kappa (F(1, 480)= 6.588, p= 0.011, ƞ2= 0.014) and leaf fraction
(F(1, 480)= 15.948, p < 0.001, ƞ2= 0.032), with higher kappa and
leaf fraction scores with increasing age.
Sensitivity analysis
The replication of our findings with age-matched groups (see
Supplementary Materials: Sensitivity Analysis and Supplementary
Tables 6 and 7 for details) showed that all results from our main
analysis were replicated except for the difference in connectivity
Table 2. Characteristics of the participant population.
HC SCP SCZ BD
Sample size 219 35 97 136
Sex % (n)*
Female 46.1% (101) 74.3% (26) 32% (31) 50.7% (69)
Male 53.9% (118) 25.7% (9) 68% (66) 49.3% (67)
Age (years)*
Mean Age (SD) 40.76 (14.532) 42.09 (15.038) 31.45 (10.551) 46.12 (11.651)
Age range (min–max) 19–78 18–65 18–74 21–73
Handedness % (n)
Right 83% (182) 74% (26) 83% (80) 87% (118)
Left 16% (36) 26% (9) 8% (8) 13 % (18)
Bilateral/N/A 1% (1) 0% (0) 9% (9) 0% (0)
Education (years)*
Mean years of education (SE) 14.03 (.184) 13.63 (.312) 12.21 (.407) 13.50 (.249)
Diagnosis % (n)
No diagnosis 100% (219) 100% (35) 0% (0) 0% (0)
Schizophrenia 0% (0) 0% (0) 53.6% (52) 0% (0)
Schizophreniform disorder 0% (0) 0% (0) 1% (1) 0% (0)
Psychosis NOS 0% (0) 0% (0) 27.9% (27) 0% (0)
Bipolar-I disorder 0% (0) 0% (0) 0% (0) 100 % (136)
Missing 0% (0) 0% (0) 17.5% (17) 0% (0)
Hallucinations % (n)
Present 0% (0) 100% (35) 82.5% (80) 52.2% (71)
Absent 98.2% (215) 0% (0) 10.3% (10) 47.8% (65)
Missing 1.8% (4) 0% (0) 7.2% (7) 0% (0)
Delusions % (n)
Present .5% (1) 34.3% (12) 68% (66) 92.6% (126)
Absent 97.3% (213) 57.1% (20) 5.2% (5) 7.4% (10)
N.A. 0% (0) 0% (0) 14.4% (14) 0% (0)
Missing 2.3 (5) 8.6% (3) 12.4% (12) 0% (0)
SPQ score n/a n/a
Total N 44 32
Mean (SD) 7.3 (6.1) 1.2 (12)
PANSS scores
Total N 42
PANSS total mean (SD) n/a n/a 63 (14) n/a
PANSS positive mean (SD) n/a n/a 15 (4) n/a
PANSS negative mean (SD) n/a n/a 15 (6) n/a
PANSS general mean (SD) n/a n/a 32 (7) n/a
Medication % (n/total n)
Antidepressants* 0% (0/219) 5.7% (2/35) 26.3% (21/80) 22.1% (30/136)
Mood stabilizers* 0% (0/219) 0% (0/35) 0% (0/97) 62.5% (85/136)
Antipsychotics* 0% (0/219) 0% (0/35) 90.6% (77/85) 48.5% (66/136)
Group differences in continuous variables were tested with one-way ANOVAs and differences in dichotomous variables were tested with Chi-Square tests.
Significant differences at p= 0.05 are marked with an asterisk (*). Subjects can be classified within several medication categories.
HC healthy controls, SCP subclinical psychosis, SCZ schizophrenia spectrum disorder, BD bipolar disorder with psychosis, SPQ schizotypo-personality
questionnaire, PANSS positive and negative symptom scale.
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strength between SCP and HC, which became nonsignificant, and
the difference in leaf fraction between SCZ and BD, which became
significant with age-matched groups. SCZ patients had lower
connectivity strength than HC (F(1, 189)= 6.956, p= 0.010, ƞ2=
0.035) and BD subjects (F(1, 117)= 8.143, p= 0.006, ƞ2= 0.065).
SCP subjects had lower connectivity strength than BD patients
(F(1, 100)= 7.123, p= 0.009, ƞ2= 0.066) but connectivity strength
was no longer significantly lower in SCP relative to HC (F(1, 100)=
3.213, p= 0.076, ƞ2= 0.031). No differences in global MST network
topology were found between SCZ, SCP, and HC. Connectivity
strength in BD patients did not significantly differ from HC.
However, BD patients had significantly lower kappa scores (less
diversity in node degree) than HC (F(1, 267)= 7.805, p= 0.006,
ƞ2= 0.028) and SCP (F(1, 100)= 7.779, p= 0.006, ƞ2= 0.072) and
lower leaf fraction scores (decreased network integration or
efficiency) than HC (F(1, 267)= 5.163, p= 0.024, ƞ2= 0.019), SCP
(F(1, 100)= 7.701, p= 0.007, ƞ2= 0.071), and SCZ (F(1, 117)=
4.801, p= 0.030, ƞ2= 0.039).
Regional network analysis
Results are visualized in Fig. 2. Regional analyses (significant at
p= 0.05 after correction for multiple comparisons) showed that
left occipital regions have a lower degree in SCP and SCZ
compared to HC. Additionally, left frontal regions have a lower
degree while the right supramarginal gyrus has a higher degree in
SCZ compared to HC. In contrast, bilateral frontal and occipital
regions have a higher degree in BD relative to HC, while right
temporal regions have a lower degree. Detailed results can be
found in the supplementary material (Section regional network
analysis, Supplementary Tables 8 and 9, Supplementary Figs. 2–4).
Medication effects
Medication effects on MST measures were examined by compar-
ing the differences on MST measures between (1) SCZ and SCP
subjects and (2) BD patients with (N= 66) and without
antipsychotic medication (N= 65) and (3) BD patients with (N=
85) and without (N= 51) lithium. Differences in global MST
network topology were found neither between SCZ patients,
medication-naïve SCP individuals, and HC, nor between BD
patients that used antipsychotics and those that did not (Tables
3 and 4, Supplementary materials).
DISCUSSION
We aimed to characterize functional connectivity and brain
network characteristics in relation to the schizophrenia spectrum
and in bipolar disorder with psychosis to disentangle neural
correlates to psychosis. We found that functional networks of SCZ
and SCP individuals are characterized by decreased MST
connectivity strength compared to HC (see Fig. 3a); however, no
differences in network topology were found. Interestingly, SCP
and SCZ individuals did not differ from each other. Functional
networks of BD patients seem to be topologically different in that
their networks are less centralized, less integrated, and less
efficient compared to HC (see Fig. 3b) while no differences in
connectivity strength were found. Our findings indicate that
disconnection characterizes functional networks of both SCZ and
BD patients with psychosis. However, in SCZ this might be due to
a global decrease in connectivity strength, whereas network
topological differences are found in BD compared to other groups.
Importantly, this indicates that distinct neural correlates are
related to psychosis in BD as compared to SCP and SCZ. Our study
mostly included SCZ patients with chronic symptoms as well as
euthymic BD patients and thereby the SCZ and BD groups can be
considered stable; differences in functional brain networks
between SCZ and BD are therefore not related to a psychotic
state, but may reflect trait differences between these groups.
Our findings are in-line with previous research showing
decreased structural and functional connectivity in SCZ12,14,21
including an MST study that found decreased strength of
structural connections but no differences in global MST topology
in SCP and SCZ15. Together, these results are contradicting prior
studies that reported increased functional connectivity21,30 and
network topology differences in SCZ20. We suggest that less strict
or no correction for possible connectivity strength effects in these
studies may have led to less accurate estimations of network
topology17,21. We found that medication effects cannot explain
our results, as was already suggested by a prior study31. The fact
that connectivity strength differences were found between SCZ
and HC, while no topological differences were found, indicates
that altered network topology is not a driving pathophysiological
disease characteristic in SCZ. Rather, topographical characteristics
Table 3. Group differences in minimum spanning tree measures.
df F p η2 Mean SE
Group differences in MST measures
Connectivity strength
Age 1480 1.31 0.255 0.003
Sex 1480 5.85 0.016* 0.012
Education 1480 3.78 0.063 0.008
Group 3480 5.62 0.001* 0.034
HC 0.639 0.004
SCP 0.618 0.009
SCZ 0.616 0.006
BD 0.640 0.005
Diameter
Group 3480 1.05 0.371 0.006
HC 0.108 0.001
SCP 0.108 0.003
SCZ 0.111 0.002
BD 0.111 0.002
Kappa
Age 1480 6.59 0.011* 0.014
Sex 1480 1.33 0.249 0.003
Education 1480 0.041 0.867 <0.001
Group 3480 4.09 0.007* 0.025
HC 2.840 0.008
SCP 2.867 0.020
SCZ 2.835 0.013
BD 2.802 0.011
Leaf fraction
Age 1480 15.95 <0.001* 0.032
Sex 1480 0.822 0.365 0.002
Education 1480 0.492 0.515 0.001
Group 3480 3.49 0.016* 0.021
HC 0.472 0.002
SCP 0.478 0.004
SCZ 0.471 0.003
BD 0.465 0.002
Group differences were tested with ANCOVAs with age, sex, and education
as covariates and the Benjamini–Hochberg FDR correction for multiple
testing. Significant differences at p= 0.05 are marked with an asterisk (*).
HC healthy controls, SCP subclinical psychosis, SCZ schizophrenia spectrum
disorder, BD bipolar disorder with psychosis.
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of connectivity alterations, meaning the anatomical localization of
network topology characteristics, may be specific to the disease.
Connectivity strength and MST topology did not differ between
SCP and SCZ individuals. Previous work on cortical thickness and
structural brain networks found that SCZ patients deviated more
from controls than SCP individuals13,16,32 including a prior MST
study using a partially overlapping dataset15. The lack of
differences between SCP and SCZ individuals might be due to
the small sample size of the SCP group. However, based on the
small F values (<1.00) and effect sizes (~.01) of the post-hoc tests
we do not expect to find a clinically relevant difference with a
larger sample. Our global MST findings regarding BD are contra-
dicting with research reporting no global differences in the
structural connectome in (high risk for) BD22,25, similar distur-
bances in BD and SCZ33–35 or studies suggesting a spectrum with
SCZ having decreased connectivity than HC and BD patients being
intermediate36. Our results are also contrasting structural con-
nectivity findings indicating that bipolar disorder is characterized
by reduced global efficiency, impaired interhemispheric connec-
tivity, and an unaffected rich club26. However, these studies are
based on structural rather than functional MRI scans, and results
relate to BD in general rather than to BD patients with a history of
psychosis, which might explain the discrepancy to our results.
Regional MST alterations differ between SCZ and BD: In SCZ,
frontal and occipital regions are more affected while in BD
alterations are found in the temporal areas. Again, this might
indicate that distinct neural correlates are related to psychosis in
BD as compared to SCP and SCZ. Our findings replicated previous
reports of decreased connectivity in frontal regions in SCZ and
SCP17,20,21,35. Importantly, SCZ patients show increased connectiv-
ity in the right supramarginal gyrus, which might be related to
auditory hallucinations since disrupted connectivity in language
areas in SCP and SCZ might play a role in the experience of
hallucinations37. This result is of interest in the light of findings of
less lateralized language function in SCZ, with the right hemi-
sphere showing increased language activity38. While the left
hemisphere is language-dominant in HC, language function seems
to be more bilateral in SCZ. Sommer et al.38 suggested that this
might be due to increased language-related activity in the right
hemisphere, which is consistent with our finding of increased
connectivity in right-hemisphere language areas. Findings regard-
ing BD are consistent with research reporting weaker structural
connectivity in a subnetwork including the Rolandic operculum
and neighboring fronto-temporal areas25,26.
We found no effect of antipsychotics or lithium on connectivity
strength and MST topology as there was difference in MST
measures neither between medication-naïve SCP individuals and
SCZ patients, nor between BD patients that used antipsychotics or
lithium and those that did not. This is in-line with findings that
antipsychotic medication does not influence the blood-
oxygenation-level-dependent signal in fMRI studies and is not
significantly associated with connectivity measures20,25,31. How-
ever, it should be noted that several studies reported functional
connectivity strength and network topology changes after
treatment with antipsychotic medication, and that the SCP group
may differ from medication naïve schizophrenia patients39–43. The
effects of antidepressants and/or other mood stabilizers were
not considered in this study but were not expected to affect
findings25.
Strengths of this study are the direct comparisons of large,
transdiagnostic samples with strict correction for motion effects
and other confounders in network analysis including connectivity
strength. A limitation of this study is that the groups differed in
age, although our main findings were replicated in age-matched
subgroups. Differences in age might suggest different disease
stages, which may lead to different network organization44. Our
SCZ cohort mainly consisted of chronic SCZ patients where
network characteristics might contrast most with HC. Detailed
data on disease duration were not available in our sample.
Assessment of psychotic symptoms differed between groups, as a
transdiagnostic instrument for the characterization of these
symptoms such as the Questionnaire of Psychotic Experiences
was not yet available during data collection45. However, we do not
expect that other definitions of psychotic symptoms would lead to
significant differences in our main findings. Regarding our
methodology, we used the current state of art methodological
pipeline but we cannot ensure that using other methods (e.g.,
using echo-planar fMRI, another atlas or connectivity measure, or
using a seed-based or independent component analysis
approach) might lead to different results.
Fig. 2 Visualization of regional degree differences between the networks of psychosis groups and age-matched healthy controls. The
nodal size corresponds to their degree. Blue nodes mark regions that do not differ compared to healthy controls, while red nodes mark
regions with a lower degree and green nodes mark regions with a higher degree compared to controls. HC healthy controls, SCP subclinical
psychosis, SCZ schizophrenia spectrum disorder, BD bipolar disorder with psychosis.
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In conclusion, functional networks may reflect a psychosis trait
rather than state with different signatures for patients/healthy
subjects in the schizophrenia spectrum compared to patients with
bipolar disorder, which could not be explained by antipsychotic
medication effects. No functional network alterations were found
in the schizophrenia spectrum after strict correction for con-
nectivity strength, suggesting that connectivity strength effects
may have confounded previous functional network studies.
METHODS
Participants
We included 97 patients with schizophrenia spectrum disorder, 136
patients with bipolar-I disorder, 35 individuals with subclinical psychotic
experiences, and 219 healthy controls. Participants were recruited between
2006 and 2018 via the Dutch Bipolar Cohort (BD, HC4,46), The Outcome of
Psychosis Fitness Therapy (SCZ, HC47), the Spectrum (SCP, SCZ, HC48), the
Understanding Hallucinations (SCZ, HC; clinicaltrials.gov identifier
NCT02460965), or the Simvastatin for recent onset psychosis studies
(SCZ, HC49). All participants were above 18 years and had no diagnosis of
alcohol or substance abuse disorders or somatic disorders (e.g.,
cardiovascular, neuromuscular, or endocrine disorders)47,48. The SCZ group
had a diagnosis of schizophrenia, schizophreniform disorder, or psychosis
not otherwise specified according to the DSM-IV1, had a lifetime history of
hallucinations and/or delusions (as assessed by the Structured Clinical
Interview for DSM-IV, SCID-I50, and the Comprehensive Assessment of
Symptoms and History Interview, CASH51) and was stable on antipsychotic
medication for at least 4 weeks before inclusion47,49. Subjects with a
diagnosis of schizoaffective disorder (N= 12, 11%) were excluded to
ensure contrast in the comparison between SCZ and BD. The BD group
showed a lifetime history of hallucinations and/or delusions but was
euthymic at the time of inclusion52. The SCP group had psychotic
experiences at least once a month, had no diagnosis of an Axis I psychiatric
disorder other than anxiety or depressive disorders in full remission, and
was not using any psychiatric medication32,48,53. Two patients were using
antidepressants in the SCP group, which is similar to the use of
antidepressants in the general population; no other psychiatric medication
was used in this group. The absence of a psychiatric diagnosis in the SCP
group can be disputed since the criterion persistent hallucinations would
be sufficient for a diagnosis of psychosis not otherwise specified (NOS).
However, the general terms of the DSM state that a diagnosis should only
be made if the symptoms and/or dysfunction bother the individual socially
or occupationally, which was not the case in our study. The control group
(recruited via all studies) included individuals with no current diagnosis but
a history of depressive disorder (N= 17; 7.7%), ADHD (N= 1; 0.5%), PTSD
(N= 1; 0.5%), adjustment disorder (N= 1; 0.5%), specific phobia (N= 2;
0.9%), mild alcohol use disorder (N= 3; 1.4%), conduct disorder (N= 1;
0.5%), or eating disorder (N= 1; 0.5%). Three controls (1.4%) were excluded
due to the use of antidepressant medication. Characteristics of the
participants are summarized in Table 2. Participants gave written informed
consent and the studies were approved by the affiliated Institutional
Review Board and conducted in accordance with the Declaration of
Helsinki.
Image acquisition and processing
Scans were acquired with a 3T Achieva Philips clinical MRI scanner
equipped with an 8-channel SENSE head coil at the University Medical
Center Utrecht (Philips, Best, The Netherlands). For anatomical reference,
3D high-resolution T1-weighted images were obtained with echo time
[TE]= 4.6 ms, repetition time [TR]= 10ms, flip angle= 8°, Field of View
(FOV)= 240mm/100%, voxel size= 0.75 × 0.75 × 0.80mm, and reconstruc-
tion matrix= 200 × 320 × 320. For subjects recruited via the Spectrum
study48, T1-weighted images were of lower resolution (160 contiguous
sagittal slices, TE= 4.6 ms, TR= 10ms, flip angle= 8°, FOV= 224mm,
voxel size= 1 × 1 × 1mm). Apart from the T1-weighted images, all other
scanning parameters were similar across studies so that it was not
expected to impact our study. Resting-state functional MRI scans were
acquired by combining a 3D PRESTO pulse sequence with parallel imaging
(SENSE) in two directions leading to a fast functional brain coverage every
609ms54. Parameters were set to 40 coronal slices, TE= 32.4 ms, TR=
21.75ms, flip angle= 10°, FOV= 224 × 256 × 160, voxel size= 4 × 4 ×
4mm. Depending on the study, 600–1000 images were acquired. All
resting-state scans were resized to the first 600 images (~6min) and were
checked for radiological abnormalities.
Images were processed using the FMRIB Software Library (FSL) version
5.0.455. For preprocessing, FEAT’s default settings were used including skull
stripping (BET), motion correction with MCFLIRT, spatial smoothing (5 mm
kernel at full width at half maximum), and high-pass filtering (100-second
cutoff). No global signal regression was performed as this could influence
network topology analyses and group comparisons56. A systemic motion-
related bias was prevented by excluding subjects whose relative root
mean square displacement overall frames exceeded 0.2 mm or if 20
individual frames all exceeded the threshold of 0.25mm57. ICA-AROMA
was used to correct for in-scanner motion since it removes motion-related
variance from the BOLD signal together with white matter and cerebral
spinal fluid regressors58,59. From the initial 672 subjects analyzed,
185 subjects were excluded (HC N= 51; SCP N= 8; SCZ N= 54; BD N=
72) due to missing clinical data, processing errors, motion artifacts, or
radiological exclusions resulting in 487 subjects included for further
analysis (see Supplementary Table 1 for details).
Table 4. Medication differences in minimum spanning tree measures.
df F p Mean SE
Antipsychotic medication effects on MST measures
Connectivity strength
Group 1126 0.524 0.470
BD/AP 0.641 0.006
BD/nAP 0.635 0.006
Diameter
Group 1126 0.817 0.368
BD/AP 0.112 0.002
BD/nAP 0.109 0.002
Kappa
Group 1126 <0.001 0.990
BD/AP 2.802 0.013
BD/nAP 2.802 0.013
Leaf fraction
Group 1126 0.008 0.929
BD/AP 0.467 0.003
BD/nAP 0.467 0.003
Lithium effects on MST measures
Connectivity Strength
Group 1131 3.702 0.057
BD/li+ 0.632 0.005
BD/li− 0.648 0.008
Diameter
Group 1131 1.131 0.290
BD/li+ 0.109 0.002
BD/li− 0.113 0.002
Kappa
Group 1131 0.972 0.326
BD/li+ 2.800 0.013
BD/li− 2.819 0.014
Leaf fraction
Group 1131 0.150 0.699
BD/li+ 0.466 0.003
BD/li− 0.469 0.003
Group differences were tested with ANCOVAs with age, sex, and education
as covariates and the Benjamini–Hochberg FDR correction for multiple
testing.
HC healthy controls, SCP subclinical psychosis, SCZ schizophrenia spectrum
disorder, BD bipolar disorder with psychosis, BD/AP bipolar disorder with
antipsychotic use, BD/nAP bipolar disorder without antipsychotic use,
BD/li+ bipolar disorder with lithium use, BD/li− bipolar disorder without
lithium use.
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Connectivity analysis
Time series of each voxel across the brain were extracted and averaged
across 264 functional regions according to the atlas described by Power
et al.60. Subsequently, the brain network was reconstructed as a weighted
graph from the resulting 264 time series. The cortical, subcortical, and
cerebellar regions of the atlas described by Power and colleagues60 were
used to define the graph’s nodes. Functional connections between nodes
are represented as edges. Wavelet decompositions were applied to each of
the time series, extracting wavelet coefficients in scale 4 (0.05–0.10 Hz)61,62.
For wavelet filtering, the maximal overlap discrete wavelet transform
(MODWT) method was used in the WMSTA toolbox (http://www.atmos.
washington.edu/~wmsta/) in Matlab R2015b (The Mathworks, Inc). The
edge weight or the strength of a connection was estimated by the wavelet
coherence between the wavelet coefficients of two regions. The wavelet
coherence was calculated using Welch’s overlapped averaged period-
ogram method63 for all possible node pairs, resulting in a weighted
functional connectivity matrix of the size 264 × 264 for each subject.
Minimum spanning tree analysis
Conventional graph theoretical measures might be influenced by the
number of connections in the network and the connectivity strength27–29,64.
For instance, lower connectivity strength is often found in patients as
compared to control populations, which leads to lower values for network
measures thereby confounding group comparisons of network topology28.
To overcome these issues, the MST can be constructed, which is a
subnetwork of the original graph that connects all nodes without forming
loops and represents the network’s backbone27,29. The MST is relatively
insensitive to differences in connectivity strength thereby enabling group
comparisons of brain networks from different populations provided a similar
number of nodes and a unique MST29,65.
Connectivity strength was defined as the mean of the edge weights in
the MST matrix. MST diameter, kappa, and leaf fraction were calculated to
characterize global network topology (see Fig. 1 and Table 1). Diameter
measures the longest distance between the two most remote nodes in the
network27,29, similar to the path length in conventional graph analysis.
Kappa is a measure of diversity in nodal degree (kappa= <degree2>/
<degree>). Leaf fraction quantifies the fraction of nodes in the whole
network that have only one connecting edge and thereby is a measure of
network integration, with higher leaf fraction indicating more integrated
network topology. For regional network analyses, the degree and
betweenness centrality were calculated (see Fig. 1): The degree states
how many edges connect to a node27,29. Betweenness centrality measures
how likely it is to pass a given node when connecting any two other nodes
in the network. Together, these regional measures describe the nodal
importance within the network.
Statistical analysis
Statistical analyses were performed in IBM SPSS Statistics 25. Differences in
subject characteristics were tested with one-way ANOVAs and Chi-Square
tests. Normality of each outcome measure per group was assessed using
the Shapiro–Wilk test and Q-Q plots. The Pearson correlation between
motion (relative mean displacement) and connectivity strength was
calculated to assure that motion did not confound the functional
connectivity measures. As main analysis, we tested for group differences
in global MST measures with ANCOVAs using the complete samples with
age, sex, and years of education as covariates and Tukey LSD post-hoc
tests. To correct for potential type I errors, the Benjamini–Hochberg
procedure was used to correct for multiple testing. As sensitivity analysis,
we manually matched the groups on age since age differences might bias
differences in connectivity strength and brain network topology.
Exploratory post-hoc ANCOVAs using the matched groups with age, sex,
and education as covariates were performed to validate global MST group
differences. Additionally, Matlab R2015b (The Mathworks, Inc) was used to
investigate differences in local MST topology (i.e., differences in nodal
degree and betweenness centrality) between the age-matched groups
using permutation tests (10,000 permutations, Monte Carlo 2-sided test,
Family Wise Error adjusted). To further check for medication effects, we
repeated the ANCOVAs on global MST measures and the regional
permutation tests comparing BD patients with (N= 66) and without
antipsychotic medication (N= 65), and BD patients with (N= 85) and
without (N= 51) lithium. The significance level for all statistical tests was
set at p < 0.05.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
Fig. 3 Different neural mechanisms to psychosis in the schizophrenia spectrum and bipolar disorder. a In the schizophrenia spectrum, the
resting-state MRI network is characterized by decreased connectivity strength, while the topology of the network does not differ from
controls. b In patients with bipolar disorder with a history of psychosis, the connectivity strength does not differ from controls, but the
network topology is less integrated.
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